BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21148362)

  • 1. Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?
    Roberts L
    Science; 2010 Dec; 330(6010):1466-7. PubMed ID: 21148362
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious disease. An ill wind, bringing meningitis.
    Roberts L
    Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 5. [Africa: towards the eradication of meningitis A?].
    Nau JY
    Rev Med Suisse; 2011 Jun; 7(300):1378-9. PubMed ID: 21815540
    [No Abstract]   [Full Text] [Related]  

  • 6. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of serogroup A meningococcal conjugate vaccine for Africa.
    Stuart JM
    Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
    LaForce FM; Djingarey M; Viviani S; Preziosi MP
    Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of science. Tackling meningitis in Africa.
    Thorsteinsdóttir H; Sáenz TW
    Science; 2012 Dec; 338(6114):1546-7. PubMed ID: 23258878
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa.
    Sambo L; Chan M; Davis S; Lake A; Berkley S; Poonawalla C; Elias CJ
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S387-8. PubMed ID: 26553663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
    Chippaux JP; Debois H; Saliou P
    Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningitis A conjugate vaccine comes on stream.
    Ahmad K
    Lancet Infect Dis; 2003 May; 3(5):263. PubMed ID: 12726961
    [No Abstract]   [Full Text] [Related]  

  • 15. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The beginning of the end for the African meningitis belt?].
    Holen Ö
    Tidsskr Nor Laegeforen; 2011 May; 131(9-10):924. PubMed ID: 21755648
    [No Abstract]   [Full Text] [Related]  

  • 18. Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.
    Okwo-Bele JM; LaForce FM; Borrow R; Preziosi MP
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S389-90. PubMed ID: 26553664
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project.
    Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.